Affinity DataKi: 1nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 5nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 15nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 25nMAssay Description:Reversible Inhibition constants of the compound against IL-1 beta converting enzyme (ICE)More data for this Ligand-Target Pair
Affinity DataKi: 1.00E+3nMAssay Description:Binding affinity to FXa (unknown origin)More data for this Ligand-Target Pair
Affinity DataKi: 1.10E+3nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.26E+4nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
Affinity DataKi: 1.91E+4nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
Affinity DataKi: 5.01E+4nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
Affinity DataKi: 6.61E+4nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
Affinity DataKi: 7.24E+4nMAssay Description:Inhibition of SARS CoV 3C-like proteaseMore data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.100nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetMitogen-activated protein kinase 10(Homo sapiens (Human))
National Clinical Research Center For Geriatrics
Curated by ChEMBL
National Clinical Research Center For Geriatrics
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of JNK3 (unknown origin)More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.400nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human FXa using chromogenic substrateMore data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-gamma serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.5nMAssay Description:Inhibition of recombinant N-terminal GST tagged AKT2 (108 to 479 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptid...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair
TargetRAC-alpha serine/threonine-protein kinase(Homo sapiens (Human))
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Nanjing Chia-Tai Tianqing Pharmaceutical
Curated by ChEMBL
Affinity DataIC50: 0.600nMAssay Description:Inhibition of recombinant AKT1 (104 to 480 end residues) (unknown origin) catalytic domain expressed in Sf21 cells using peptide substrate incubated ...More data for this Ligand-Target Pair